Your browser doesn't support javascript.
loading
Different concentrations and volumes of p-phenylenediamine in pet. (equivalent doses) are associated with similar patch test outcomes: a pilot study.
Andersen, Flemming; Hamann, Carsten R; Andersen, Klaus E; Hamann, Dathan; Sager, Eric; Hamann, Curtis.
Afiliación
  • Andersen F; Department of Dermatology and Allergy Centre, Odense University Hospital, Odense 5000, Denmark, and Dermatological Investigations Scandinavia, Department of Clinical Research, University of Southern Denmark, Odense 5230, Denmark.
  • Hamann CR; Department of Dermatology and Allergy, Herlev and Gentofte Hospital, University of Copenhagen, Hellerup 2900, Denmark.
  • Andersen KE; School of Health and Medical Science, Graduate Programme in Public Health and Epidemiology, University of Copenhagen, Copenhagen 1165, Denmark.
  • Hamann D; Department of Dermatology and Allergy Centre, Odense University Hospital, Odense 5000, Denmark, and Dermatological Investigations Scandinavia, Department of Clinical Research, University of Southern Denmark, Odense 5230, Denmark.
  • Sager E; Division of Dermatology, Department of Medicine, The Ohio State University, Columbus, OH 43230, USA.
  • Hamann C; Loma Linda University School of Medicine, Loma Linda, CA 92350, USA.
Contact Dermatitis ; 78(5): 335-340, 2018 May.
Article en En | MEDLINE | ID: mdl-29392743
ABSTRACT

BACKGROUND:

Concern about causing active sensitization when patch testing is performed with p-phenylenediamine (PPD) 1% pet. has led to a recommendation to use PPD 0.3% pet. as a potentially safer preparation. However, the dose per area of allergen delivered, and hence the risk of active sensitization, depend on the amount dispensed into the patch test chamber, which can vary widely.

OBJECTIVE:

To evaluate whether patch testing with equivalent doses of different concentrations of PPD in pet. is associated with similar outcomes.

METHODS:

Seventeen known PPD-sensitive subjects were patch tested with different volumes and concentrations of PPD in pet. that deliver the same allergen dose per unit area (6 mg of PPD 1% pet. and 20 mg of PPD 0.3% pet. in Finn Chambers®, both equivalent to ∼ 0.09 mg/cm2 ).

RESULTS:

Eleven patients (65%) had positive reactions to both doses; 4 patients (24%) had negative results [percentage agreement of 88% (15/17)]. One patient each had a positive reaction to only one dose.

CONCLUSIONS:

The 88% concordance suggests that dose per unit area is more important in determining reactions to allergens than the excipient volume dispensed. Patch testing with a smaller volume of 1% PPD may be a reasonable alternative to testing with 20 mg of 0.3% PPD.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Fenilendiaminas / Pruebas del Parche / Colorantes Tipo de estudio: Observational_studies / Risk_factors_studies Límite: Female / Humans / Male / Middle aged Idioma: En Revista: Contact Dermatitis Año: 2018 Tipo del documento: Article País de afiliación: Dinamarca

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Fenilendiaminas / Pruebas del Parche / Colorantes Tipo de estudio: Observational_studies / Risk_factors_studies Límite: Female / Humans / Male / Middle aged Idioma: En Revista: Contact Dermatitis Año: 2018 Tipo del documento: Article País de afiliación: Dinamarca